Milton C. Ault III - 27 Dec 2022 Form 4 Insider Report for Alzamend Neuro, Inc. (ALZN)

Role
10%+ Owner
Signature
/s/ Milton C. Ault, III
Issuer symbol
ALZN
Transactions as of
27 Dec 2022
Net transactions value
+$2,277
Form type
4
Filing time
29 Dec 2022, 05:00:12 UTC
Previous filing
23 Dec 2022
Next filing
30 Dec 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ALZN Common Stock Purchase $532 +900 +0.01% $0.5910 11,046,901 27 Dec 2022 By Ault Lending, LLC F1
transaction ALZN Common Stock Purchase $1,745 +3,100 +0.03% $0.5629 11,050,001 28 Dec 2022 By Ault Lending, LLC F1, F2
holding ALZN Common Stock 2,500,000 27 Dec 2022 Direct
holding ALZN Common Stock 365,000 27 Dec 2022 By Ault Alpha LP F3
holding ALZN Common Stock 14,942,984 27 Dec 2022 By Ault Life Sciences, Inc. F4
holding ALZN Common Stock 10,000,000 27 Dec 2022 By Ault Life Sciences Fund, LLC F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Ault Lending, LLC ("Ault Lending"), is a wholly-owned subsidiary of BitNile Holdings, Inc. ("BH"). Mr. Ault, the Executive Chairman of BH, is deemed to have voting and investment power with respect to the securities held of record by Ault Lending.
F2 The common stock was purchased by the reporting person in open market transactions on the transaction date, with a volume weighted average purchase price of $0.5629. The range of purchase prices on the transaction date was $0.5594 to $0.5754 per share. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each price.
F3 Milton C. Ault, III, is the Manager of Ault Alpha GP LLC ("Ault GP") and Ault Capital Management LLC ("AC Management"). Ault GP and AC Management are the general partner and investment manager to Ault Alpha LP, respectively. As such, Mr. Ault is deemed to beneficially own the shares held by Ault Alpha LP.
F4 Mr. Ault has sole voting and investment power with respect to the securities held of record by Ault Life Sciences, Inc.
F5 Mr. Ault has sole voting and investment power with respect to the securities held of record by Ault Life Sciences Fund, LLC.